(Q36586033)

English

Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease

scientific article published on July 1, 1990

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

1 reference

Europe PubMed Central

Interactions between glutamatergic and monoaminergic systems within the basal ganglia--implications for schizophrenia and Parkinson's disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease (English)

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

0 references

Parkinson's disease

1 reference

based on heuristic

inferred from title

author name string

M. Carlsson

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1695402

31 October 2022

A. Carlsson

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1695402

31 October 2022

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1695402

31 October 2022

publication date

1 July 1990

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

full work available at URL

https://api.elsevier.com/content/article/PII:016622369090108M?httpAccept=text/xml

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

https://api.elsevier.com/content/article/PII:016622369090108M?httpAccept=text/plain

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

Trends in Neurosciences

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

272-276

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia

1

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

Presynaptic dopaminergic modulation of cortical input to the striatum

2

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

Stimulation of D2-dopamine receptors in rat neostriatum inhibits the release of acetylcholine and dopamine but does not affect the release of γ-aminobutyric acid, glutamate or serotonin

3

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

On the use of lesions of afferents to localize neurotransmitter receptor sites in the striatum

4

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

Evoked release of endogenous amino acids from rat striatal slices and its modulation

5

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

The current status of the dopamine hypothesis of schizophrenia

6

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

Tyrosine hydroxylase-immunoreactive boutons in synaptic contact with identified striatonigral neurons, with particular reference to dendritic spines

8

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

The effects of cortical ablation on multiple unit activity in the striatum following dexamphetamine

9

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

The role of afferents from the parafascicular-centromedian complex in the excitatory striatal neuronal response to dexamphetamine in freely moving animals

10

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity.

12

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

Effect of MK-801 on the decrease in tryptophan hydroxylase induced by methamphetamine and its methylenedioxy analog

13

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

Phencyclidine (PCP) receptors: autoradiographic localization in brain with the selective ligand, [3H]TCP.

14

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

British Journal of Pharmacology

15

97

576

author name string

Hudson

publication date

1989

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice

16

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted mice

17

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats

19

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine

21

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

Catecholamine release within the striatum of the freely moving rat.

23

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

GABAergic and glycinergic mechanisms within the substantia nigra: Pharmacological specificity of dopamine-independent contralateral turning behavior and interactions with other neurotransmitters

24

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

Intrastriatal injection of DL-2-amino-5-phosphonovaleric acid (AP-5) induces sniffing stereotypy that is antagonized by haloperidol and clozapine

25

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

Antagonism of the hypermotility response induced by excitatory amino acids in the rat nucleus accumbens

26

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

In vivo demonstration of the enhancement of MK-801 by L-glutamate

27

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

Dyskinesia in the primate following injection of an excitatory amino acid antagonist into the medial segment of the globus pallidus

28

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

Feline subthalamic nucleus neurons contain glutamate-like but not GABA-like or glycine-like immunoreactivity

29

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

30

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat.

33

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

Sensory gating in schizophrenics and normal controls: effects of changing stimulation interval

34

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

(3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients

35

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

Increased [3H]kainic acid binding in the prefrontal cortex in schizophrenia

36

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

Physostigmine and haloperidol treatment of acute phencyclidine intoxication

41

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

The effect of MK-801 and other antagonists of NMDA-type glutamate receptors on brain-stimulation reward

42

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

Possible abuse potential of the NMDA antagonist MK-801.

43

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

Effect of the NMDA antagonist MK-801 on MPTP-induced parkinsonism in the monkey

44

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

Marked locomotor stimulation in monoamine-depleted mice following treatment with atropine in combination with clonidine

46

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

Electroconvulsive shock and postsynaptic catecholamine effects: Increased psychomotor stimulant action of apomorphine and clonidine in reserpine pretreated mice by repeated ECS

47

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

British Journal of Pharmacology

48

80

373

author name string

Green

publication date

1983

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

Predictors for improvement after electroconvulsive therapy in parkinsonian patients with on-off symptoms

50

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

Tricyclic antidepressants block N-methyl-D-aspartate receptors: similarities to the action of zinc

51

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

Tricyclic antidepressants block N-methyl-D-aspartic acid-induced lethality in mice

52

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

The functional anatomy of basal ganglia disorders

53

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

Muscarinic receptors on dopamine terminals in the cat caudate nucleus: Neuromodulation of [3H]dopamine release in vitro by endogenous acetylcholine

54

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

N-methyl-D-aspartate-type receptors mediate striatal 3H-acetylcholine release evoked by excitatory amino acids

56

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

Differential effects of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism in freely moving rats

57

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

Glutamate and aspartate immunoreactivity in cortico-cortical neurons of the sensorimotor cortex of rats

58

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

Glutamate and aspartate immunoreactivity in corticospinal neurons of rats

59

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

Synaptic localization of striatal NMDA, quisqualate and kainate receptors

60

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

Excitatory amino acids and the basal ganglia: implications for the therapy of Parkinson's disease

61

1 reference

10.1016/0166-2236(90)90108-M

https://api.crossref.org/works/10.1016/0166-2236(90)90108-M

31 October 2022

Identifiers

10.1016/0166-2236(90)90108-M

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36586033&oldid=1761963020"